Hims & Hers will sell real Ozempic in deal with Novo Nordisk
Hims & Hers and the Danish pharma giant Novo Nordisk have ended a bitter legal feud that will…
The era of $199 copycat weight loss drugs is ending — and it could cost patients
After two splashy Super Bowl commercials focused on making weight loss medication more accessible, Hims & Hers will…
Taking the new Wegovy pill every day is really complicated. Will patients stick with it?
Last Updated: Feb. 11, 2026 at 8:59 a.m. ETFirst Published: Feb. 10, 2026 at 3:48 p.m. ET Patients are thrilled…
The most controversial Super Bowl ad of 2025 is back for more
Super Bowl Sunday is the holy grail of advertising thanks to its massive viewership, with an average of…
Hims launches $49 compounded copy of Wegovy weight-loss pill
By Amina Niasse NEW YORK, Feb 5 (Reuters) – Online telehealth company Hims and Hers Health will start…
Hims & Hers stock falls after Novo Nordisk ends weight loss drug pact
Investing.com — Hims & Hers Health (NYSE:HIMS) stock plunged 20% after pharmaceutical giant Novo Nordisk (NYSE:NVO) announced it…